Featured Posts
The WHO Measles and Rubella (MR) Team invites you to a global webinar on "Best practices and lessons learned on Measles and Rubella campaign".
Panelists from country, regional, and HQ levels will share:
Best practices, challenges, and lessons learned from recent campaign implementation
Co...
Posts
A child received 2 dose of mesales vaccine 7 to 8 months ago and child developed the measles symptom. Both IgM and PCR test are positive for measles. Can this be a false positive ?...
Four years into its strategic plan, the Measles & Rubella Partnership's Midterm Review reveals that while progress has been made, countries and global institutions must take urgent, collective action to reach elimination targets by 2030.
At the end of 2024, 83 countries had eliminated measles a...
What percentage of children will likely get measles even after receiving two or more doses of the measles vaccine?...
Colleagues,I am sharing a concise analysis of Cameroon’s WUENIC 2024 results with targeted, system-level recommendations. The brief synthesises a decade of trends (2015–2024), highlights equity gaps, and proposes practical fixes aligned with IA2030.Key findings (snapshot):-HepB birth dose remains at...
🛡️ When Should We Conduct a Measles-Rubella Vaccination Campaign? (Latest WHO Global Guidance) 🌍 GIS can be the game changer!
As a Surveillance & Immunization Medical Officer, I often get asked:
❓ “When is the right time for a Measles-Rubella (MR) campaign?”
Here’s my field-tested, WHO-aligne...
Background
The dissemination of the interim guidance is intended for national immunization programme managers, campaign decision-makers and global, regional and country-level policy-makers and partners responsible for the design, implementation, monitoring and evaluation of measles and rubella vacc...
The MOMENTUM Routine, Immunization, Transformation and Equity project aims to strengthen routine immunization programs to overcome the entrenched obstacles contributing to stagnating and declining immunization rates. As part of this work, we would love to gather any feedback you may have on your exp...
HISP Rwanda et l'Université d'Oslo ont le plaisir de vous inviter à la prochaine Académie DHIS2 en français sur les outils d’analyse, Niveau 1 qui se tiendra du 21 au 26 août 2023 à l'hôtel Galaxy de Kigali, au Rwanda.
L'Académie sur les outils d'Analyse donne l'opportunité de comprendre les princi...
Dear colleagues,
The conclusions of the Global Measles and Rubella Strategic Plan 2012–2020 implementation midterm review highlighted the need to update protocols for guiding surveillance and outbreak investigation and response.
To that end, WHO and partners have developed the ...
Dear TechNet-21 Members,
The annual WHO and UNICEF national estimates of immunization coverage (WUENIC) 2022 here were officially released on15th July.
You can access all data here: https://immunizationdata.who.int/ and https://data.unicef.org/topic/child-health/immunizati...
Would you like to know more about using DHIS2 for disease surveillance, early warning and outbreak detection? We invite you to join us for a high-level introduction to Disease Surveillance organized by the University of Oslo which will take place on 28 April (in French) and 4 May (in English). This ...
When: Tuesday, March 15, 2022 3:30PM - 4:30PM (CET)
Location: https://gavi-org.zoom.us/webinar/register/WN_Wx9c2pSFS7yXCBMKN98cjg
Registration Link: https://gavi-org.zoom.us/webinar/register/WN_Wx9c2pSFS7yXCBMKN98cjg
Panelists:
• Sheldon Halsted, Linksbridge • Robert Steinglass (for...
Dear Colleagues,
I would like to bring to your attention that the Summary Tables of WHO Routine Immunization Recommendations have been updated. The latest versions (November 2021) of the Summary Tables (available in both FRENCH and ENGLISH) can be downloaded from the WHO website (htt...
Many thanks for attending the session on measles and rubella microarray patches. Follow the URL below to see the session in case you have missed it:
https://www.youtube.com/watch?v=wAcQx5SI6c8
Below I summarise key discussion points from the session:
• The few remaining countries that...
Since 1998, WHO and UNICEF annually collect data on national immunization systems through the WHO/UNICEF Joint Reporting Form on Immunization (JRF). The JRF collects national level data on reported cases of selected vaccine-preventable diseases, immunization coverage, recommended immunization schedu...
Greetings, everyone. I hope that you are healthy and keeping your spirits up amidst these trying times.
In March this year, just before COVID-19 shutdowns, I visited health facilities in Kinshasa - where mothers were being asked to wait (one for over 2 hours) and turned away for measles vaccination...
The challenge before us is an enormous one – many lives hang in the balance. But never in the history of the world have we had as many resources available to craft solutions as we do today. When a Covid-19 vaccination is developed, we have the benefit of innovative homegrown tech that already exists...
An Immunization Pulse Poll in the context of COVID-19 conducted between 14 and 24 April, with 801 responses from 107 countries, showed that disruption to the routine immunization program are widespread and affect all WHO regions. 64% of countries represented in the poll indicated that routine immuni...
PROMOTING EQUITY THROUGH SUPPLY CHAIN DESIGN
June 3, 2020, 4:00-5:00pm CEST
REGISTER HERE: https://who.zoom.us/webinar/register/WN_EoDaBqqkRaSFRLgKo9Fk6Q
Join VillageReach and JSI for a discussion on how supply chains can be adapted to be more responsive to the needs of under-served populat...
We have MR Vaccine for a campaign that had to be suspended due to current COVID-19 circumstances. These vaccines had been stored between minus 15 and minus 25 deg C at the Primary Store. Later, Vaccines were supplied to the District stores where they had been stored between plus 2 and 8 deg C.
We w...
There are no discussions available here currently